# Xilio Therapeutics, Inc.: Form 8-K, filed Jun 10, 2025

- Company: [Xilio Therapeutics, Inc.](/companies/xlo.md) (CIK 1840233)
- Form: 8-K
- Filed: 2025-06-10
- Accepted by EDGAR: Jun 10, 2025, 20:35 ET
- Period: 2025-06-10
- Accession: 0001558370-25-008512
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1840233/000155837025008512/xlo-20250610x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840233/000155837025008512/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840233/000155837025008512/xlo-20250610x8k.htm

Filed Jun 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001558370-25-008512. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.